Synonyms: | |
Status: | Approved (2009) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | L01EX03 |
UNII: | 7RN5DR86CK |
InChI Key | CUIHSIWYWATEQL-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H23N7O2S |
Molecular Weight | 437.53 |
AlogP | 3.14 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 119.03 |
Molecular species | NEUTRAL |
Aromatic Rings | 4.0 |
Heavy Atoms | 31.0 |
Primary Target | |
---|---|
fms related receptor tyrosine kinase 1 | |
fms related receptor tyrosine kinase 4 | |
kinase insert domain receptor |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 4 | D009369 | ClinicalTrials |
Neoplasms | 4 | D009369 | ClinicalTrials |
Sarcoma | 3 | D012509 | ClinicalTrials |
Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
Sarcoma | 3 | D012509 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Neoplasms, Germ Cell and Embryonal | 2 | D009373 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Chondrosarcoma | 2 | D002813 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
Telangiectasia, Hereditary Hemorrhagic | 2 | D013683 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Glioma | 2 | D005910 | ClinicalTrials |
Solitary Fibrous Tumors | 2 | D054364 | ClinicalTrials |
Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
Lymphedema | 2 | D008209 | ClinicalTrials |
Leiomyosarcoma | 2 | D007890 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Liposarcoma | 2 | D008080 | ClinicalTrials |
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
Osteosarcoma | 2 | D012516 | ClinicalTrials |
Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Lung Neoplasms | 2 | D008175 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Sarcoma, Alveolar Soft Part | 2 | D018234 | ClinicalTrials |
Gliosarcoma | 2 | D018316 | ClinicalTrials |
Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
Dermatofibrosarcoma | 2 | D018223 | ClinicalTrials |
Macular Degeneration | 2 | D008268 | ClinicalTrials |
Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
Corneal Neovascularization | 1 | D016510 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Psoriasis | 1 | D011565 | ClinicalTrials |
Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 444731-52-6 |
ChEBI | 71219 |
ChEMBL | CHEMBL477772 |
DrugBank | DB06589 |
DrugCentral | 4118 |
EPA CompTox | DTXSID8048733 |
FDA SRS | 7RN5DR86CK |
Guide to Pharmacology | 5698 |
PubChem | 10113978 |
SureChEMBL | SCHEMBL588608 |
ZINC | ZINC000011617039 |